MARC: Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC)

Permalink:	http://skupni.nsk.hr/Record/nsk.NSK01000036867/Details
Matična publikacija:	Libri oncologici 22 (1993), 2 ; str. 101-106
Glavni autor:	Kolarić, Krsto (-)
Ostali autori:	Roth, Anton (-), Žigman, Miroslav, Bradamante, Vlasta, Rogan-Grgas, Jadranka
Vrsta građe:	Članak
Jezik:	eng
Predmet:	Dojka, tumori > Terapija, farmakološka


LEADER	01173caa a2200325 ir4500
001	NSK01000036867
003	HR-ZaNSK
005	20111028105500.0
008	940209s1993 ci \|\|\| \|\|eng
015			\|a HP93-2328 \|2 HR
035			\|9 (HR-ZaNSK)36903
035			\|9 (HR-ZaNSK)940209197
035			\|a (HR-ZaNSK)000036867
040			\|a HR-ZaNSK \|b hrv \|c HR-ZaNSK \|e ppiak
041	0		\|a eng \|b hrv
080			\|a 618.19-006
100	1		\|a Kolarić, Krsto
245	1	0	\|a Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC) / \|c Krsto Kolarić, Anton Roth, Miroslav Žigman, Vlasta Bradamante and Jadranka Rogan.
300			\|b Ilustr.
504			\|a Bibliografija: 30 jed.
504			\|a Sažetak
653	0		\|a Dojka, tumori \|a Terapija, farmakološka
700	1		\|a Roth, Anton
700	1		\|a Žigman, Miroslav
700	1		\|a Bradamante, Vlasta
700	1		\|a Rogan-Grgas, Jadranka
773	0		\|t Libri oncologici \|x 0300-8142 \|g 22 (1993), 2 ; str. 101-106 \|w nsk.(HR-ZaNSK)000011357
932			\|a da \|b znanstveni rad
981			\|p CRO
886	0		\|2 unimarc \|b 00953naa2 2200241 450